BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

336 related articles for article (PubMed ID: 37554691)

  • 1. Korean Society of Heart Failure Guidelines for the Management of Heart Failure: Management of the Underlying Etiologies and Comorbidities of Heart Failure.
    Park SM; Lee SY; Jung MH; Youn JC; Kim D; Cho JY; Cho DH; Hyun J; Cho HJ; Park SM; Choi JO; Chung WJ; Kang SM; Yoo BS;
    Int J Heart Fail; 2023 Jul; 5(3):127-145. PubMed ID: 37554691
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Korean Society of Heart Failure Guidelines for the Management of Heart Failure: Management of the Underlying Etiologies and Comorbidities of Heart Failure.
    Park SM; Lee SY; Jung MH; Youn JC; Kim D; Cho JY; Cho DH; Hyun J; Cho HJ; Park SM; Choi JO; Chung WJ; Kang SM; Yoo BS;
    Korean Circ J; 2023 Jul; 53(7):425-451. PubMed ID: 37525389
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced External Counterpulsation (EECP): An Evidence-Based Analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2006; 6(5):1-70. PubMed ID: 23074496
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Comorbidity in heart failure].
    Widmer F
    Ther Umsch; 2011 Feb; 68(2):103-6. PubMed ID: 21271541
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Non-cardiac comorbidities in heart failure: an update on diagnostic and management strategies.
    Kodur N; Tang WHW
    Minerva Med; 2024 Jun; 115(3):337-353. PubMed ID: 38899946
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of Heart Failure With Preserved Ejection Fraction in Elderly Patients: Effectiveness and Safety.
    Elkammash A; Tam SSC; Yogarajah G; You J
    Cureus; 2023 Feb; 15(2):e35030. PubMed ID: 36938226
    [TBL] [Abstract][Full Text] [Related]  

  • 7. American College of Cardiology/American Heart Association Chronic Heart Failure Evaluation and Management guidelines: relevance to the geriatric practice.
    Ahmed A
    J Am Geriatr Soc; 2003 Jan; 51(1):123-6. PubMed ID: 12534856
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Contemporary epidemiology and treatment of hospitalized heart failure patients in real clinical practice in China].
    Wang H; Li YY; Chai K; Zhang W; Li XL; Dong YG; Zhou JM; Huo Y; Yang JF
    Zhonghua Xin Xue Guan Bing Za Zhi; 2019 Nov; 47(11):865-874. PubMed ID: 31744275
    [No Abstract]   [Full Text] [Related]  

  • 9. [Management of comorbidities in heart failure].
    Peperstraete B
    Rev Med Brux; 2013; 34(3):154-62. PubMed ID: 23951855
    [TBL] [Abstract][Full Text] [Related]  

  • 10. What Is New in Heart Failure Management in 2017? Update on ACC/AHA Heart Failure Guidelines.
    Bozkurt B
    Curr Cardiol Rep; 2018 Apr; 20(6):39. PubMed ID: 29667019
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comorbidity health pathways in heart failure patients: A sequences-of-regressions analysis using cross-sectional data from 10,575 patients in the Swedish Heart Failure Registry.
    Lawson CA; Solis-Trapala I; Dahlstrom U; Mamas M; Jaarsma T; Kadam UT; Stromberg A
    PLoS Med; 2018 Mar; 15(3):e1002540. PubMed ID: 29584734
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute heart failure admissions in New South Wales and the Australian Capital Territory: the NSW HF Snapshot Study.
    Newton PJ; Davidson PM; Reid CM; Krum H; Hayward C; Sibbritt DW; Banks E; MacDonald PS
    Med J Aust; 2016 Feb; 204(3):113.e1-8. PubMed ID: 26866550
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiac and Noncardiac Disease Burden and Treatment Effect of Sacubitril/Valsartan: Insights From a Combined PARAGON-HF and PARADIGM-HF Analysis.
    Rohde LE; Claggett BL; Wolsk E; Packer M; Zile M; Swedberg K; Rouleau J; Pfeffer MA; Desai AS; Lund LH; Kober L; Anand I; Merkely B; Senni M; Shi V; Rizkala A; Lefkowitz M; McMurray JJV; Solomon SD
    Circ Heart Fail; 2021 Mar; 14(3):e008052. PubMed ID: 33706551
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical Implications of Functional Mitral Regurgitation Severity in Patients with Heart Failure with Reduced Ejection Fraction (HFrEF).
    Naser N
    Med Arch; 2022 Feb; 76(1):17-22. PubMed ID: 35422569
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A review of heart failure management in the elderly population.
    Cheng JW; Nayar M
    Am J Geriatr Pharmacother; 2009 Oct; 7(5):233-49. PubMed ID: 19948300
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Focused Update of 2016 Korean Society of Heart Failure Guidelines for the Management of Chronic Heart Failure.
    Kim KJ; Cho HJ; Kim MS; Kang J; Kim KH; Kim D; Seo SM; Yang JH; Cha MJ; Choi JI; Choi DJ
    Int J Heart Fail; 2019 Oct; 1(1):4-24. PubMed ID: 36262736
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Atrial fibrillation and heart failure in cardiology practice: reciprocal impact and combined management from the perspective of atrial fibrillation: results of the Euro Heart Survey on atrial fibrillation.
    Nieuwlaat R; Eurlings LW; Cleland JG; Cobbe SM; Vardas PE; Capucci A; López-Sendòn JL; Meeder JG; Pinto YM; Crijns HJ
    J Am Coll Cardiol; 2009 May; 53(18):1690-8. PubMed ID: 19406345
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A review of current key guidelines for managing high-risk patients with diabetes and heart failure and future prospects.
    Lee MMY; Sattar N
    Diabetes Obes Metab; 2023 Jul; 25 Suppl 3():33-47. PubMed ID: 37041663
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Total management of chronic obstructive pulmonary disease (COPD) as an independent risk factor for cardiovascular disease.
    Onishi K
    J Cardiol; 2017 Aug; 70(2):128-134. PubMed ID: 28325523
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathogenesis of chronic heart failure: cardiovascular aging, risk factors, comorbidities, and disease modifiers.
    Triposkiadis F; Xanthopoulos A; Parissis J; Butler J; Farmakis D
    Heart Fail Rev; 2022 Jan; 27(1):337-344. PubMed ID: 32524327
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.